Boothbay Fund Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-46,557
Closed -$463K 2116
2021
Q3
$463K Hold
46,557
0.01% 928
2021
Q2
$460K Buy
+46,557
New +$460K 0.01% 916